Your shopping cart is currently empty

DSPE-PEG-NHS, MW 2000 is a PEG-modified phospholipid derivative designed for the formulation of liposomes. Frequently, DSPE-PEG-NHS, MW 2000 is utilized as a linker molecule to modify liposome surfaces, thereby enhancing their targeting capabilities. Additionally, DSPE-PEG-NHS, MW 2000 is applicable in research focused on drug delivery systems.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $47 | - | In Stock | |
| 10 mg | $70 | - | In Stock | |
| 25 mg | $119 | - | In Stock | |
| 50 mg | $178 | - | In Stock | |
| 100 mg | $267 | - | In Stock | |
| 500 mg | $588 | - | In Stock |
| Description | DSPE-PEG-NHS, MW 2000 is a PEG-modified phospholipid derivative designed for the formulation of liposomes. Frequently, DSPE-PEG-NHS, MW 2000 is utilized as a linker molecule to modify liposome surfaces, thereby enhancing their targeting capabilities. Additionally, DSPE-PEG-NHS, MW 2000 is applicable in research focused on drug delivery systems. |
| In vitro | DSPE-PEG-NHS, MW 2000, is an amphiphilic polymer that includes DSPE, PEG, and NHS groups, known for its biocompatibility and low toxicity, and is frequently used in drug modification. |
| Storage | In solvent: -80°C for 1 year |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.